SCHEMBL660312

SCHEMBL660312

Fc1cccc(-c2ccc3cnsc3c2Br)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
PIK3R1 P27986 1/20 0.37
PIK3CA P42336 1/20 0.37
MEN1 O00255 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
IDO1 P14902 2/20 0.35
NT5E P21589 1/20 0.35
PIM1 P11309 3/20 0.34
CDK2 P24941 3/20 0.34
GSK3B P49841 3/20 0.34
PLK4 O00444 2/20 0.34
AURKA O14965 2/20 0.34
DAPK3 O43293 2/20 0.34
CHEK2 O96017 2/20 0.34
CDK1 P06493 2/20 0.34
FLT4 P35916 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660443 0.74 LPL (0.35) KDM4EMEN1MAPTKMT2APIM1
SCHEMBL659713 0.71 SLC22A12 (0.31) SLC22A12
SCHEMBL28373609 0.65 KDM4E (0.41) KDM4EHPGDNPSR1RXFP1PIK3R1
SCHEMBL30541518 0.65 KDM4E (0.41) KDM4EHPGDNPSR1RXFP1PIK3R1
SCHEMBL22648191 0.64 TAAR1 (0.41) KDM4EMEN1MAPTKMT2APIM1
SCHEMBL658073 0.63 NOS1 (0.39)
SCHEMBL8071753 0.63 TRPM5 (0.39) KDM4EHPGDMEN1MAPTKMT2A
SCHEMBL10269901 0.63 ALOX5AP (0.45) KDM4EHPGDNPSR1RXFP1PIK3R1
SCHEMBL31408657 0.62 MAPK1 (0.58) KDM4EHPGDNPSR1RXFP1PIK3R1
SCHEMBL3564382 0.62 MAPK1 (0.58) KDM4EHPGDNPSR1RXFP1PIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 KDM4E 117/4885HPGD 2213/4885NPSR1 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.